Hu v. Janssen Pharmaceuticals

District Court, N.D. California·Decided September 11, 2024·No. 4:21-cv-05990·Unknown

Opinion

SOPHIE HU, et al., Case No. 21-cv-05990-HSG

Plaintiffs, ORDER DENYING PLAINTIFF'S MOTION FOR APPOINTMENT OF v. COUNSEL

JANSSEN PHARMACEUTICALS, INC., et Re: Dkt. No. 45 al., Defendants. Before the Court is Plaintiff Sophie Hu’s motion for appointment of counsel, Dkt. No. 45. The Court finds this matter appropriate for disposition without oral argument and the matter is deemed submitted. See Civil L.R. 7-1(b). The Court DENIES the motion. Plaintiff filed her original complaint against Defendants in this Court in August 2021. Dkt. No. 1. She filed an amended complaint later that month. Dkt. No. 8. In December 2021, her case was transferred to the Eastern District of Louisiana for inclusion in coordinated proceedings there. Dkt. No. 39. The Judicial Panel on Multidistrict Litigation remanded the case back to this Court in January 2024. Dkt. No. 40. Plaintiff filed a motion for appointment of counsel in February 2024. See Dkt. No. 45 (“Mot.”) at 4–5. Plaintiff’s amended complaint alleges that her mother, Fumian Zhao, experienced a cerebellar hemorrhage due to her use of the medication Xarelto, causing her extreme pain and suffering and leaving her incapacitated. See Dkt. No. 8 (“FAC”) ¶¶ 6–11. Plaintiff brings various product liability claims against Defendants as the makers of Xarelto, most of which appear based on a failure-to-warn theory of liability. See id. ¶¶ 12–17. She seeks compensation for the compensate injury, pain, loss, and suffering to [her] entire family.” Id. ¶ 18. Despite Plaintiff’s sustained efforts over several years to find representation, she has appeared pro se throughout the litigation. See Dkt. No. 65 at 2. “The court may ask counsel to represent an indigent litigant under 28 U.S.C. § 1915 only in ‘exceptional circumstances,’ the determination of which requires an evaluation of both (1) the likelihood of success on the merits, and (2) the ability of the plaintiff to articulate her claims pro se in light of the complexity of the legal issues involved.” Brown v. Cnty. of Del Norte, No. 16-CV- 07235-RMI, 2018 WL 11364271, at *1 (N.D. Cal. Feb. 13, 2018) (quoting Wilborn v. Escalderon, 789 F.2d 1328, 1331 (9th Cir. 1986)).1 The Court finds in its discretion that no exceptional circumstances warrant appointment of counsel. Plaintiff lacks the ability to prosecute her claims in this case pro se not because the legal issues involved are complex, but because she may not bring her viable claims, all of which she asserts on her mother’s behalf, without representation as a matter of law. See C.E. Pope Equity Tr. v. United States, 818 F.2d 696, 697 (9th Cir. 1987); Johns v. County of San Diego, 114 F.3d 874, 877 (9th Cir. 1997).2 Despite what she describes as her best efforts, Plaintiff has not been able to find counsel to take her case, and she remains unrepresented. See Mot. at 3–4. Accordingly, because she lacks standing, her likelihood of success on the merits at this time is essentially zero. Moreover, the Court understands that Plaintiff has spoken to the Federal Pro Bono Project about her potential eligibility for pro bono counsel, but the Project similarly has been unable to identify counsel willing to represent her. Under these circumstances, it would be inappropriate for the Court to effectively force an unwilling attorney to represent Plaintiff. See Mot. at 3 (representing

1 Section 1915(e) grants courts the discretion to request an attorney to represent a person “unable to afford counsel.” 28 U.S.C. § 1915(e). Plaintiff has never submitted a request to this Court to proceed in forma pauperis, but for purposes of this order, the Court will assume Plaintiff meets the statute’s indigency requirement, as that would seem to be the only possible basis for her motion.

2 The Eastern District similarly denied the motion for appointment of counsel that Plaintiff filed in the MDL, finding that her case did not present legal complexities “more severe than those 1 that attorneys Plaintiff consulted, including Xarelto MDL counsel, told her that it would “be 2 irresponsible for any knowledgeable attorney to take a new Xarelto case” and said they were “not 3 aware of any counsel currently taking new Xarelto claims”). 4 Ii. CONCLUSION 5 The Court DENIES Plaintiff's motion for appointment of counsel. 7 Dated: 9/11/2024 8 . ° mag S. GILLIAM, JR. / 9 United States District Judge 10 11 a 12

15 16

= 17

Z 18 19 20 21 22 23 24 25 26 27 28

Free access — add to your briefcase to read the full text and ask questions with AI

Hu v. Janssen Pharmaceuticals, (N.D. Cal. 2024).

Hu v. Janssen Pharmaceuticals (Hu v. Janssen Pharmaceuticals) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related